§ BIOTECHNOLOGY
USD · BiotechnologyCCCC
C4 THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
110 increased/new, 31 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Morgan Stanley | 9.1M | 0.0% | n/a |
| RA CAPITAL MANAGEMENT, L.P. | 8.0M | 0.2% | ±0% |
| Bain Capital Life Sciences Investors, LLC | 7.2M | 1.7% | ±0% |
| Lynx1 Capital Management LP | 7.0M | 2.9% | −1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | n/a | n/a |
| Soleus Capital Management, L.P. | 3.8M | 0.4% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for CCCC as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER8.2% · 0 holders
OTHER58.9% · 90 holders
DEALER / BANK19.9% · 14 holders
TACTICAL / MACRO4.2% · 3 holders
PASSIVE / INDEX3.8% · 6 holders
SYSTEMATIC / QUANT2.8% · 4 holders
ACTIVIST1.1% · 1 holder
QUALITY / COMPOUNDER1.0% · 5 holders
INCOME / DEFENSIVE0.1% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CCCC in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention CCCC yet.